Prot #BGB-3111-304: An International, Phase 3, Open-label, Randomized Study of BGB-3111 Compared with Bendamustine plus Rituximab in Patients with Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Project: Research project

Project Details

StatusActive
Effective start/end date2/5/192/5/22

Funding

  • PRA Health Sciences (Prot #BGB-3111-304)
  • BeiGene Ltd. (Prot #BGB-3111-304)